| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Fundraising > Email Fundraising Campaigns Must Inspire Donors to Go Online |
|
Digg It - Email Fundraising Campaigns Must Inspire Donors to Go Online
Sending an email with no links to follow is like mailing
a direct mail appeal without enclosing a reply device
or return envelope. Cost According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ly. Email fundraising only works when you inspire donors to go online. Online is where you get their donation. Online is where ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in you secure their advocacy. Online is
where you encourage their involvement. That’s why
your email appeals, alerts and newsletters must lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ive
donors something to do, and must give them
somewhere to go to do it. That place is your
website. Websites alone might r here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ise some funds but they
won’t build relationships. And email letters might
inform donors but they won’t advance your cause
unless you d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro drive those donors to your website to
act. The easiest way to show you what I mean is to show you how Mothers Against Drunk D ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc iving does it. Their
email newsletters are filled with links. Down the right side of each email donor newsletter is a simple, easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ertical navigation bar that looks like
this: >> HELP SUPPORT MADD By making a donation today, you’re making a dif nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically erence for tomorrow. More>> >> VICTIM SERVICES After the crash, there’s the impact. MADD is here to help you. More and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ >>
>> TAKE ACTION TODAY! Learn what simple things you can do to help save lives and prevent injuries. More >> ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi > >> FORWARD TO A FRIEND Share the latest news with your family and friends. More >> Why this is effective: ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a 1. It’s strategic. MADD has a three-fold mission, Activism, Victim Services and Education. These simple, consistent links in e dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ery newsletter
advance that mission by encouraging subscribers to
speak out (Take Action Today!), help victims (Victim
Services) and cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin educate others (Forward to a
Friend). 2. It’s donor-centered. Notice that every one of these four links speaks directly tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen to “you,” the
donor. “You” are making a difference. “You” can save
lives. MADD is here to help “you.” 3. It teases. Eac t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel link tells you just enough
to understand what lies on the other end of
that “More >>” link, but no more. You must click the
link to ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust atisfy your curiosity. 4. It stresses action. Three of the four links contain active verbs. “Help support,” “Take actio y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products n,” “Forward.” In direct mail we call this
the “call to action.” It calls the reader to act. The
quickest way to encourage your donor t . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de donate,
sign a petition, take a survey or simply read more is
to command them to do so. To see what this entire email newslet elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Minding Your Own Brand - Do You Love Me?
|